Annual Current Liabilities
$5.96 M
-$5.82 M-49.42%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual total current liabilities is $5.96 million, with the most recent change of -$5.82 million (-49.42%) on December 31, 2023.
- During the last 3 years, NRBO annual current liabilities has risen by +$2.27 million (+61.30%).
- NRBO annual current liabilities is now -49.42% below its all-time high of $11.78 million, reached on December 31, 2022.
Performance
NRBO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$9.11 M
-$597.00 K-6.15%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly total current liabilities is $9.11 million, with the most recent change of -$597.00 thousand (-6.15%) on September 30, 2024.
- Over the past year, NRBO quarterly current liabilities has increased by +$3.15 million (+52.92%).
- NRBO quarterly current liabilities is now -36.84% below its all-time high of $14.43 million, reached on June 30, 2016.
Performance
NRBO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NRBO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.4% | +52.9% |
| 3 y3 years | +61.3% | +379.4% |
| 5 y5 years | +2621.5% | +196.6% |
NRBO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.4% | +176.3% | -22.7% | +629.7% |
| 5 y | 5-year | -49.4% | +186.3% | -22.7% | +865.5% |
| alltime | all time | -49.4% | +2621.5% | -36.8% | +4061.6% |
NeuroBo Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.11 M(-6.1%) |
| Jun 2024 | - | $9.71 M(+42.3%) |
| Mar 2024 | - | $6.83 M(+14.5%) |
| Dec 2023 | $5.96 M(-49.4%) | $5.96 M(+26.2%) |
| Sep 2023 | - | $4.72 M(+18.6%) |
| Jun 2023 | - | $3.98 M(-63.7%) |
| Mar 2023 | - | $10.98 M(-6.8%) |
| Dec 2022 | $11.78 M(+446.3%) | $11.78 M(+627.9%) |
| Sep 2022 | - | $1.62 M(+29.6%) |
| Jun 2022 | - | $1.25 M(-16.5%) |
| Mar 2022 | - | $1.50 M(-30.6%) |
| Dec 2021 | $2.16 M(-41.6%) | $2.16 M(+13.5%) |
| Sep 2021 | - | $1.90 M(+60.7%) |
| Jun 2021 | - | $1.18 M(+25.3%) |
| Mar 2021 | - | $944.00 K(-74.5%) |
| Dec 2020 | $3.69 M | $3.69 M(+2.2%) |
| Sep 2020 | - | $3.62 M(+15.4%) |
| Jun 2020 | - | $3.13 M(-15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.71 M(+78.0%) |
| Dec 2019 | $2.08 M(+850.7%) | $2.08 M(-32.2%) |
| Sep 2019 | - | $3.07 M(+49.9%) |
| Jun 2019 | - | $2.05 M(+19.7%) |
| Mar 2019 | - | $1.71 M(+681.7%) |
| Dec 2018 | $219.00 K(-96.6%) | $219.00 K(-97.1%) |
| Sep 2018 | - | $7.62 M(+22.6%) |
| Jun 2018 | - | $6.21 M(-0.7%) |
| Mar 2018 | - | $6.26 M(-2.1%) |
| Dec 2017 | $6.39 M(+55.1%) | $6.39 M(+1.5%) |
| Sep 2017 | - | $6.29 M(+19.4%) |
| Jun 2017 | - | $5.27 M(+16.0%) |
| Mar 2017 | - | $4.54 M(+10.2%) |
| Dec 2016 | $4.12 M(-53.8%) | $4.12 M(+112.9%) |
| Sep 2016 | - | $1.94 M(-86.6%) |
| Jun 2016 | - | $14.43 M(+540.7%) |
| Mar 2016 | - | $2.25 M(-74.7%) |
| Dec 2015 | $8.92 M(+914.4%) | $8.92 M |
| Dec 2014 | $879.00 K | - |
FAQ
- What is NeuroBo Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual current liabilities year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly current liabilities year-on-year change?
What is NeuroBo Pharmaceuticals annual total current liabilities?
The current annual current liabilities of NRBO is $5.96 M
What is the all time high annual current liabilities for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual total current liabilities is $11.78 M
What is NeuroBo Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, NRBO annual total current liabilities has changed by -$5.82 M (-49.42%)
What is NeuroBo Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of NRBO is $9.11 M
What is the all time high quarterly current liabilities for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly total current liabilities is $14.43 M
What is NeuroBo Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, NRBO quarterly total current liabilities has changed by +$3.15 M (+52.92%)